Of note is that a major hallmark of an aggressive HCC is its ability to metastasize [63]; the recurrence of HCC supports the metastatic KPT-330 Verdinexor (KPT-335)? phenomenon. The observed increased expression of RCC1 is one of the most important members of the RAN signaling pathway, which is involved in the nucleocytoplasmic transport of macromolecules [64, 65]. Recent findings have shown that silencing RAN expression could induce more apoptosis in cancer cells, Inhibitors,Modulators,Libraries and therefore is a promising cancer therapeutic target [66]. This suggests a novel link between the elevated RAN signaling pathway Inhibitors,Modulators,Libraries in HCC recurrence and a potentially important role for nucleo-cytoplasmic transport mechanisms of RCC1 during HCC progression. The increased expression of RIOK3 is known to alter the cytoskeletal architecture, as well as promoting pancreatic ductal cell migration and invasion [30].

The increased expression of RIOK3 has been Inhibitors,Modulators,Libraries observed in metastatic head and neck cancers compared with nonrecurrent tumors [67]. These observations raise an interesting prospect that similarly, increased expression of RIOK3 may contribute to cytoskeletal architecture alteration to influence cell migration and tumor invasion in HCC patients having tumor recurrence. Thus, the findings of the present study further point toward new avenues of research aimed at evaluating the impact of Inhibitors,Modulators,Libraries anti-apoptosis, cytoskeletal architecture alteration, and RAN signaling on HCC recurrence. A limitation of this study was the use of only 50% of the FFPE tissue with microarray analysis and the low number of tissues used for the final analysis.

Further investigation with larger cohort is warranted. Comparing Inhibitors,Modulators,Libraries specific subgroups of different liver diseases, races/ethnicities, ages, and tumor characteristics could reveal clinical implications that could potentially aid in patient selection for liver transplantation. Future studies with recent advanced technology such Next Generation RNA Sequencing (RNA-seq) might offer greater potential for the use of FFPE samples, with a tremendous increase in the number of samples to study. RNA-seq, a recently developed approach to transcriptome profiling that uses deep-sequencing technologies [68], could offer a greater opportunity to use FFPE samples [8, 69] to bring gene expression results into the clinical treatment of HCC. In conclusion, this pilot expression profiling study using FFPE tissue has shown that stored FFPE tissue is a vital resource and has identified molecular patterns for HCC-R tumor tissue consistent with prior studies. We also identified Entinostat a set of genes not previously reported to be associated with HCC-R. All of these genes may be potential targets for future therapeutic interventions. Conflict of Interests No conflict of interests was disclosed.